Clinical Trials

Colorado Springs Neurological Associates is one of the largest and longest-standing neuroscience medical practices in southern Colorado.  Our aim is to deliver the highest standard of neurological care – the same level of care we would want for ourselves or our loved ones.  The Center has a dedicated clinical research institute with experienced principal investigators and a full-time research staff.  Collectively, our investigators have vast experience conducting phase II through phase IV clinical trials in a broad range of neurologic diseases affecting adults and children.


 

Multiple Sclerosis Clinical Trials

Title: Acthar Gel: A prospective observational registry of H.P Acthar Gel for the treatment of Multiple Sclerosis relapse
Sponsor: Mallinckrodt
Principle Investigator: Christen Kutz, PhD, PAC

Title: A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study Comparing the Efficacy and Safety of ofatumumab administered subcutaneously versus teriflunomide administered orally in patients with relapsing forms of Multiple Sclerosis Eligibility and information
Sponsor: Novartis:
Principle Investigator: Kimberly Wagner, MD

Title: A Prospective, Observational Cohort Study in Adults Patients with Relapsing Multiple Sclerosis to Assess Patient Safety during and after Lemtrada Infusions of the First Treatment Course
Sponsor: Genzyme
Principle Investigator: Laurence Adams, MD

Title: PASS
A Prospective, Multicenter, Observational Post-Authorization Safety Study to Evaluate the Long Term Safety Profile of Lemtrada Treatment in Patients with Relapsing Forms of Multiple Sclerosis
Sponsor: Genzyme
Principle Investigator: Laurence Adams, MD

Other Clinical Trials

Epilepsy

Title: A Phase III Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Study To Evaluate The Efficacy and Safety of Lacosamide as Adjunctive Therapy for Uncontrolled Primary Generalized Tonic-Clonic Seizures in Subjects With Idiopathic Generalized Epilepsy (SP0982 Study) and in the long term follow-up Study (EP0012) Eligibility and information
Sponsor: UCB
Principle Investigator: Kimberly Wagner, MD

Parkinson’s Disease

Title: Effects of droxidopa when measuring gait speed, kyphosis, and functional reach in Parkinson’s disease.
Sponsor: Lundbeck
Principle Investigator: Laurence Adams, MD

Autonomic Dysfunction

Title: “Restore” Phase 4 Clinical Study of droxidopa in Patients with Symptomatic Neurogenic Orthostatic Hypotension- pending Eligibility and information
Sponsor: Lundbeck
Principle Investigator: Laurence Adams, MD

 

Ischemic Stroke

TF0023: Phase 2, multi-center, randomized, double-blind, parallel group, dose-range finding study to evaluate the efficacy and safety of TF0023 spray versus placebo in functional improvement of patients with ischemic strokes under standard of care Eligibility and information
Sponsor: Techfields
Principle Investigator: Kimberly Wagner, MD

Multiple Sclerosis Medical Marijuana Study

About the Study
We are seeking people with Multiple Sclerosis who use medical marijuana. The purpose of this questionnaire is to understand how medical marijuana affects the symptoms of patients with Multiple Sclerosis in Colorado. We plan to use the data collected in this questionnaire to give healthcare professionals and patients’ current information on medical marijuana so they can make the informed decisions.

Confidentiality
Your personal identifying information will remain confidential. All information is voluntary and anonymous.

About the Questionnaire
The questionnaire contains questions that are fill in the blank and check mark boxes. The questionnaire will take between 5 and 10 minutes to complete.

Principle Investigator: Christen Kutz, PhD, PAC

 

Research Staff